Replies to post #6024 on Taxus Cardium Pharmaceuticals Group Inc (CRXM)

[campe]

When it was trading, there really wasn't enough volume to indicate shorting. With that said, it shouldn't have prevented keeping up with filings.

I always thought CRXM would have been a good reverse merge candidate for Norstrom. (good exit strategy for principals).

Glad to see SEC go after Sabby...